Clinical trials

What are clinical trials?

Clinical trials and research are a critical part of bringing new medicines to patients. Through the data generated from clinical trials, we answer important scientific questions and gain a better understanding about the efficacy and safety of these study medicines and their potential as treatment options for patients.

Bristol Myers Squibb clinical trials

It is our policy to provide patients, healthcare providers and others with information about Bristol Myers Squibb sponsored clinical trials that are conducted on investigational compounds and marketed products. We publicly disclose study information on Bristol Myers Squibb sponsored interventional trials, as well as certain non-interventional clinical trials.

Registration of clinical trials

Bristol Myers Squibb sponsored trials are those studies in which our company is ultimately responsible for all aspects of the study, even if some or all of these activities are transferred to another party. Bristol Myers Squibb will register all Bristol Myers Squibb sponsored Phase I, II, III and IV interventional trials on www.clinicaltrials.gov and other applicable websites as required. For specific trials where Bristol Myers Squibb is not the sponsor but has agreed to carry out the disclosure responsibility of the sponsor, Bristol Myers Squibb will register the trials.

Disclosure of clinical trials

Our policy also calls for the open and timely reporting of results from Bristol Myers Squibb sponsored clinical trials involving Bristol Myers Squibb marketed products. Bristol Myers Squibb shares clinical trial results through scientific congresses or publication in peer-reviewed journals. In addition, results for clinical trials completed after 2008 on marketed products are available at www.ClinicalTrials.gov. Our goal is to present these clinical trial results in an accurate, balanced and complete manner regardless of development phase or outcome. Results will not be posted on www.ClinicalTrials.gov for new formulations of marketed products until the new formulation is approved by a regulatory agency unless the trial data is clinically relevant to the use of the marketed product. In general, results from non-Bristol Myers Squibb sponsored trials will not be reported by the company. However, for certain trials where Bristol Myers Squibb is not the sponsor but has agreed to carry out the disclosure responsibility of the sponsor, the company will post the results as required.

You may also be interested in:
The Path to Progress: Clinical trials spotlight

NO-GB-2300218
Date of preparation: September 2023